TriNetX

TriNetX, Inc. operates a global health research network that facilitates clinical research and enhances the discovery of new therapies. The company provides a suite of tools, including TriNetX Live for analyzing patient populations, TriNetX Research for accessing longitudinal clinical data, and TriNetX Download for obtaining real-world clinical data through a unified platform. Additionally, TriNetX offers Attract Trials to streamline collaboration, Natural Language Processing to extract clinical information from physician notes, and specialized oncology solutions to link researchers with clinical and genomic data. Serving healthcare organizations, biopharmaceutical companies, and contract research organizations, TriNetX aims to optimize clinical trial design and recruitment, improving the speed and efficiency of bringing new therapies to market. Established in 2013, the company is headquartered in Cambridge, Massachusetts, with additional offices in Sydney, London, and Sao Paulo.

K. Arnold Chan

Senior Vice President, Insight and Evidence Generation

3 past transactions

Clinerion

Acquisition in 2023
Clinerion Ltd, founded in 2008 and headquartered in Basel, Switzerland, specializes in healthcare technology with a focus on enhancing clinical research and patient access to treatments. The company’s flagship product, the Patient Network Explorer, leverages real-time analysis of electronic health record data from a global network of partner hospitals to provide valuable insights into disease epidemiology and patient care metrics. Clinerion’s platform facilitates data-driven protocol optimization, site feasibility evaluation, and efficient patient recruitment for clinical trials, emphasizing diversity and the identification of rare disease patients. Additionally, Clinerion offers a Federated Machine Learning Platform, which enables the training of machine learning algorithms on its extensive real-world data network, aiming to advance both drug development and preventive care. Committed to privacy and compliance with international regulations, Clinerion operates under a "privacy by design" principle, ensuring the security of patient data throughout its operations.

Advera Health Analytics

Acquisition in 2022
Advera Health Analytics is a California-based healthcare informatics company that improves patient safety and reduces systemic healthcare costs through the comprehensive analysis of post-marketing drug side effect data. Utilizing data-mining and analysis technology, through its proprietary RxSuite™ of analytics, AEI makes post-marketing drug safety data accessible, actionable, and predictable. AEI provides services to enterprise markets including managed care organizations, the pharmaceutical industry, and financial institutions.

Custodix

Acquisition in 2019
Custodix N.V. is a Belgian company that specializes in data protection solutions for eHealth, focusing on compliant data management in clinical research. Founded in 2000 and based in Sint-Martens-Latem, the company offers a range of products including Custodix Anonymisation Services, a platform for the de-identification of various data types; Patient Identity Management System, which manages patient records and identifiers; and Custodix Identity and Access Management, a security suite for managing identities in both on-premises and cloud environments. Their services also include secure reuse of electronic health records for research, trusted third-party data collection, and consultancy on data privacy and protection. As a subsidiary of TriNetX, Inc. since April 2019, Custodix ensures compliance with European and US data protection legislation, facilitating the secure and trustworthy exchange of sensitive data for research and statistical purposes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.